NeuroMetrix (NASDAQ:NURO) Share Price Passes Above Two Hundred Day Moving Average – What’s Next?

NeuroMetrix, Inc. (NASDAQ:NURO)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.11 and traded as high as $4.39. NeuroMetrix shares last traded at $4.42, with a volume of 1,085 shares changing hands.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on shares of NeuroMetrix in a research report on Wednesday, March 12th. They issued a “sell” rating for the company.

NeuroMetrix Stock Performance

The firm’s 50-day moving average is $4.28 and its two-hundred day moving average is $4.11. The stock has a market cap of $9.08 million, a P/E ratio of -0.96 and a beta of 2.15.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in NeuroMetrix stock. Renaissance Technologies LLC purchased a new stake in NeuroMetrix, Inc. (NASDAQ:NURO) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 11,560 shares of the medical device company’s stock, valued at approximately $46,000. Renaissance Technologies LLC owned 0.57% of NeuroMetrix as of its most recent SEC filing. Hedge funds and other institutional investors own 19.40% of the company’s stock.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.